Climb Bio - CLYM Net Assets per Single Share

Graphic logo of Climb Bio Inc (CLYM)

Climb Bio Inc (CLYM) operates in the non-cyclical biotech sector, where success is determined by medicine rather than economics, as reflected in this chart with the asset value at 4.19. The company is developing a comprehensive therapy system for autoimmune pathologies through B-cell suppression; however, the lack of revenue and massive research expenditures are leading to a liquidity deficit and the depletion of reserves.

Climb Bio Inc. (CLYM): Share Book Value from 10/04/2024 to 10/26/2026

climbbio.com - analytical breakdowns and key metrics (CLYM)

- price and consensus price forecast:
Stock Quotes Climb Bio, Inc.|CLYM - Average Forecast Price
- market capitalization data:
Market Value Climb Bio Inc.|CLYM - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Climb Bio|CLYM - Net Asset Value|Market Capitalization to Book Value Ratio climbbio.com|CLYM - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Climb Bio Inc|CLYM - Long-Term Debt to Capital|Short-Term Debt to Equity Climb Bio|CLYM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Climb Bio Inc.
Fundamental company valuation:Climb Bio, Inc. - CLYM
Manufactured products of Climb Bio

This indicator determines the net asset value minus all liabilities, reflecting the actual asset backing of each investment unit without speculative influence. By analyzing the book value per share, the investor assesses the resource capitalization of Climb Bio Inc., which, combined with the management's scientific expertise, confirms the efficiency of attracting venture capital to develop the immune drug pipeline.

Competitors of Climb Bio Inc (CLYM)

ARGX (Argenx) - Accounting Value per Share|BNTX: Net Asset Value per Share|ABVX (Abivax Corp) - Net Assets per Single Share|ADMA (admabiologics.com) - Accounting Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|ATXS: Book Value per Share|ENGN: Accounting Value per Share|RAPT Therapeutics, Inc. (RAPT) - Net Assets per Single Share|Aerovate Therapeutics (JBIO) - Net Assets per Single Share|ACRS: Book Value per Share|Net Assets per Share KYTX|Net Assets per Single Share TLSA (Tiziana Life Sciences PLC)|Accounting Value per Share Cabaletta Bio Inc (CABA)|Book Value per Share Ventyx Biosciences VTYX|THTX - Net Assets per Single Share|Accounting Value per Share Avalo Therapeutics (AVTX)|ELDN - Accounting Value of a Share|Agenus Inc (AGEN) - Book Value per Share|Zura Bio Ltd (ZURA) - Net Assets per Single Share|ATYR: Book Value per Share|Net Assets per Share ADAG|ImageneBio Inc - Net Assets per Single Share|Net Asset Value per Share shattucklabs.com STTK|Accounting Value per Share Equillium|Accounting Value of a Share Connect Biopharma Holdings CNTB|Book Value per Share IMUX (Immunic Inc)|ATRA: Net Assets per Share|Net Assets per Single Share inflarx.de|X4 Pharmaceuticals Inc. (XFOR) - Equity per Share|Book Value per Share ACET|Accounting Value per Share Celularity Corp|Book Value per Share INMB (INmune Bio, Inc.)|Accounting Value per Share BRNS (barinthusbio.com)|Net Assets per Single Share Kezar Life Sciences, Inc. KZR|SABS - Net Assets per Single Share|AKTX (Akari Therapeutics plc) - Accounting Value per Share|ENLV: Net Asset Value per Share|QTTB (q32bio.com) - Net Assets per Single Share|GOVX (geovax.com) - Accounting Value per Share|Net Assets per Single Share Edesa Biotech EDSA|Share Book Value iBio Inc|Carisma Therapeutics (CARM) - Book Value per Share|Accounting Value of a Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Book Value per Share|Net Assets per Single Share Aptevo (APVO)|AIM: Accounting Value of a Share|ADTX (aditxt.com) - Net Assets per Single Share|GRI Bio Corporation (GRI) - Accounting Value per Share|XRTX (XORTX Therapeutics Inc.) - Book Value per Share|Book Value per Share reshapelifesciences.com (HIND)|Revelation Biosciences, Inc. (REVB) - Accounting Value per Share|Accounting Value of a Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI|CalciMedica Inc - Net Assets per Share|AFMD: Net Assets per Single Share|ALLK: Accounting Value per Share|HOOK (hookipapharma.com) - Net Assets per Single Share|Accounting Value per Share IGM Biosciences|ITOS (iTeos) - Accounting Value per Share|Book Value per Share OCEA|Net Assets per Single Share TC Biopharm TCBP|Equity per Share thirdharmonicbio.com (THRD)